AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04663750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravitreal 20% sulfahexafluoride (SF6) gas tamponade
Description: Intravitreal 20% sulfahexafluoride (SF6) gas tamponade.
Study NCT05495971 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NaturalVue Multifocal
Description: EDOF
Study NCT06538311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active rTMS
Description: All study participants will receive one block of ACTIVE rTMS. Each block will consist of daily sessions of active rTMS delivered to the left dorsolateral prefrontal cortex over ten days (Monday through Friday).
Study NCT06538311 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham rTMS
Description: All study participants will receive one block of SHAM rTMS. Each block will consist of daily sessions of SHAM rTMS delivered to the left dorsolateral prefrontal cortex over ten days (Monday through Friday).
Study NCT06089239 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Coaching
Description: External coaching is a commonly used strategy to change practice, especially for multi-site collaboratives where implementation requires customization to the site. Coaches serve as skill builders who train organizational personnel in quality improvement processes and develop proficiency in the targeted practice area (i.e., fall prevention).
Study NCT06089239 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Low Intensity Coaching
Description: External coaching is a commonly used strategy to change practice, especially for multi-site collaboratives where implementation requires customization to the site. Coaches serve as skill builders who train organizational personnel in quality improvement processes and develop proficiency in the targeted practice area (i.e., fall prevention).
Study NCT05966662 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IVL with Shockwave C2+ 2Hz Coronary IVL Catheter
Description: Lithotripsy-enabled, low-pressure balloon dilatation of severely calcified, stenotic de novo coronary arteries prior to stenting.
Study NCT06044493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Myreptic-N Tablet
Description: Up to 720mg BID(total 1440mg daily), PO - Check the blood concentration of Mycophenolate at each visit
Study NCT06044493 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Mycophenolate mofetil Tablet/Capsule
Description: Up to 1g BID(total 2g daily), PO - Check the blood concentration of Mycophenolate at each visit
Study NCT06174987 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-DXd
Description: T-DXd (DS8201a) will be administered as an intravenous (IV) infusion, on Day 1 of each 21-day cycle according to the dosage regimens
Study NCT06616298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assessing and Listening to Individual Goals and Needs (ALIGN)
Description: Assessing and Listening to Individual Goals and Needs (ALIGN). ALIGN utilizes the skills of palliative care social workers (PCSWs) trained in family and systems-level theory to address changing preferences for care, family distress, and to facilitate communication across care transitions to improve care aligned with preferences.3 The intervention is implemented virtually in community SNFs and follows patients for 45 days after SNF discharge to reflect real-world patient flow.
Study NCT06730438 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Pulse Stimulation
Description: Patients will receive TPS once a day for five days a week, each session will be separated from the previous one by 24h. Each stimulation and assessment session will be performed at the same hour of the day, in the morning preferably, to maximize the probability of observing responses to stimuli. Patients will be managed in a quiete room with stable light and temperature.
Study NCT06730438 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Pulse Stimulation
Description: Patients will receive TPS once a day for five days a week, each session will be separated from the previous one by 24h. Each stimulation and assessment session will be performed at the same hour of the day, in the morning preferably, to maximize the probability of observing responses to stimuli. Patients will be managed in a quiete room with stable light and temperature.
Study NCT06725719 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 18F-DPA714/FDPA
Description: Each subject receive a single intravenous injection of 18F-DPA714/FDPA, and undergo PET/CT or MRI imaging within the specificed time.
Study NCT06736301 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: a fully covered stent
Description: a double pig-tail stent for cross fixation of a fully covered stent
Study NCT06736210 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Elastic Properties Measurement
Description: Using the MyotonPro device, the elastic properties, including stiffness, elasticity, and tone, were evaluated for the tibialis anterior, gastrocnemius medialis, gastrocnemius lateralis, and peroneus longus muscles. Measurements were performed in a controlled laboratory setting.
Study NCT06736210 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Oxygen Saturation (SmO2)
Description: Muscle oxygenation levels were measured before and after a standardized exercise protocol using the MOXY device. The exercise protocol consisted of a light-intensity dynamic task tailored to minimize fatigue and mimic functional activity.
Study NCT06736210 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plantar Pressure Analysis
Description: Plantar pressure was assessed both statically and dynamically using a pressure-mapping platform. This provided data on pressure distribution, contact times, and high-pressure areas across the foot during various conditions.
Study NCT06736015 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Myo-Inositol 600 mg + Selenium 83 mcg
Description: Myo-Inositol 600 mg + Selenium 83 mcg: 1 tablet once a day for 6 months
Study NCT06734429 — intervention group
Intervention type: OTHER
Intervention: Urinary Artificial Sphincter
Description: Urinary Artificial Sphincter is a device used for patients with urethral sphincter incompetence
Study NCT06734481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate pleural lavage
Description: All participants will receive a standardized antimicrobial therapy regimen, with antibiotics selected based on susceptibility testing. Within 2 days of initiating treatment, all patients will undergo catheter placement for continuous drainage of pleural effusion. Participants will receive a daily intrapleural injection of 200 mL of 2.5% sodium bicarbonate in 7 days. For patients with ultrasound evidence of pleural effusion loculations or drainage tube obstruction, intrapleural administration of urokinase may be performed at the discretion of the treating physician to ensure effective drainage.Following each daily injection, the catheter will be clamped for 2 hours before resuming continuous drainage, a process that will continue for 7 days.
Study NCT06734481 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline pleural lavage
Description: All participants will receive a standardized antimicrobial therapy regimen, with antibiotics selected based on susceptibility testing. Within 2 days of initiating treatment, all patients will undergo catheter placement for continuous drainage of pleural effusion. Participants will receive a daily intrapleural injection of 200 mL of saline in 7days For patients with ultrasound evidence of pleural effusion loculations or drainage tube obstruction, intrapleural administration of urokinase may be performed at the discretion of the treating physician to ensure effective drainage. Following each daily injection, the catheter will be clamped for 2 hours before resuming continuous drainage, a process that will continue for 7 days..
Study NCT06734260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Keverprazan Hydrochloride tablets + high dose amoxicillin
Description: Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 3 times/day, oral, for 14 day
Study NCT06734260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Keverprazan Hydrochloride tablets + low dose amoxicillin
Description: Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 2 times/day, oral, for 14 day
Study NCT06734260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Keverprazan Hydrochloride tablets + high dose amoxicillin（H-KA-10d）
Description: Keverprazan Hydrochloride tablets 20 mg/time, 2 times/day, oral Amoxicillin 1000mg/ time, 3 times/day, oral, for 10 day
Study NCT06735495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD19&CD22 bispecific CAR-T cells
Description: Each patient will receive CD19\&CD22 bispecific CAR-T cells by intravenous infusion on day 0
Study NCT06735651 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Wild Blueberry
Description: Daily consumption of 22 g of freeze-dried wild blueberry freeze-dried powder for 6 weeks
Study NCT06735651 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily consumption of 22 g of freeze-dried macronutrient-matched placebo powder for 6 weeks
Study NCT06735326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluzoparib
Description: Fluzoparib capsule (50mg per capsule) 150mg po BID
Study NCT06735326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab injection (100mg per vial) 7.5mg/kg ivdrip Q3W
Study NCT06735326 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel injection 135-175mg/㎡ ivdrip Q3W
Study NCT06735326 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin injection AUC=4-5 ivdrip Q3W
Study NCT06735313 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Periodontal examination and saliva collection
Description: Before the periodontal examination, saliva samples are collected from each patient participating in the study and periodontal measurements are made.
Study NCT06735313 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Periodontal examination and saliva collection
Description: Before the periodontal examination, saliva samples are collected from each patient participating in the study and periodontal measurements are made.
Study NCT06736145 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Physical Therapy
Description: Diaphragmatic, Pursed Lip breathing and Targeted cervical muscle stretches 10 repetitions x 1 set, 3 days/week~Total of 9 sessions were given each consisting of 40 mins.
Study NCT06736145 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mulligan Glides
Description: Natural Apophyseal Glides of Cervical spine are given 3 repetitions x 3-6 sets, 3 days/week.~Diaphragmatic, Pursed Lip breathing and Targeted cervical muscle stretches 10 repetitions x 1 set, 3 days/week~Total of 9 sessions were given each consisting of 40 mins.
Study NCT05753345 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aquatic therapy
Description: Children receive aquatic occupational therapy twice a week for 10 weeks. 30 minutes of aquatic therapy in a warm water pool to increase upper extremity function and swim skills; 15 minutes of self care training to increase independence with dressing and showering.
Study NCT05254496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary Intervention Classes
Description: Participants will attend classes once per week for 6 months and then bi-weekly for 6 months.
Study NCT06074198 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SuCCESs
Description: strengthening and endurance exercises
Study NCT04918238 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional program
Description: All the participants will receive the conventional physical therapy protocol per session as following: Infrared radiation on the low back area for 15 minutes, Ultrasound waves (Digi sonic device) for 10 minutes on the trigger areas of the low back, Myofascial release of the thoracolumbar fascia, Stretching of the Paraspinal muscles and the hamstrings, Mobilization of the lumbar and thoracic spine from a prone lying position and strengthening of abdominal muscles, multifidus and transversal's abdominal muscle.
Study NCT04918238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional program
Description: All the participants will receive the conventional physical therapy protocol per session as following: Infrared radiation on the low back area for 15 minutes, Ultrasound waves (Digi sonic device) for 10 minutes on the trigger areas of the low back, Myofascial release of the thoracolumbar fascia, Stretching of the Paraspinal muscles and the hamstrings, Mobilization of the lumbar and thoracic spine from a prone lying position and strengthening of abdominal muscles, multifidus and transversal's abdominal muscle.
Study NCT04918238 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle energy technique
Description: The patient was in the lateral recumbent position on the side opposite to his, her side-bending dysfunction while the physiotherapist stood facing the subject. The physiotherapist monitored the lumbar area with one hand while with the other hand flexed the subject's knees and hips until the barrier was engaged at the vertebral segment being treated.
Study NCT06475391 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-arginine
Description: 2 grams iof L-arginine will be ingested before an acute testing bout of exercise tasks in 250 mL of cranberry juice.
Study NCT06475391 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06426043 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lusutrombopag
Description: Administer lusutrombopag at 3mg/qd orally for 12 weeks (lusutrombopag starting dose is 3mg, once daily. After 2 weeks of continuous administration, the dose can be increased by 3mg every 2 weeks based on the platelet count and safety of the subject. The dose can be gradually increased to 9mg/d over a total of 12 weeks). The course should be at least 3 months. When the platelet increase is \<20×109/L, the daily dose can be increased by 3mg up to a maximum of 9mg/day; when the platelet increase is ≥50×10\^9/L and ≤200×10\^9/L, the dose can be maintained; when the platelet count is ≥200×10\^9/L and ≤400×10\^9/L, the daily dose can be reduced by 3mg; when the platelet count is >400×10\^9/L, the drug can be suspended and resumed when the platelet count decreases to \<200×10\^9/L, with the daily dose reduced by 3mg. In this case, if the lowest dose of 3mg/day is used, the drug can be suspended. Responders continue treatment until 6 months.
Study NCT05679284 — intervention group
Intervention type: RADIATION
Intervention: Low-dose X-ray of subcutaneous tissues
Description: To identify needle fragment retentions, the radiologic imaging of all volunteers will be performed with X-ray using radiation doses as low as reasonably achievable (ALARA) and one projection per anatomic site.
Study NCT06296134 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: perineal massage
Description: women affected by LAM co-activation allocated to the intervention perineal massage are asked to perform the perineal massage once daily from 34 gestational weeks until delivery. Women are trained to correctly perform the perineal massage at 30 gestaitonal weeks.
Study NCT06548828 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: NNS Restriction Intervention
Description: Discuss current scientific literature surrounding NNS consumption, obesity, and chronic disease and the emerging evidence that consumption in pregnancy/lactation may have unfavorable effects on infants' adiposity and health.~Provide detailed handouts, which will include a list of specific foods and beverages containing NNS to avoid during the study and summarize current scientific evidence on the metabolic and health effects of NNS.~Emphasize that sugar is not the best alternative to NNS, and that the participant should drink still water, sparkling water, flavored waters with no added sweeteners, or unsweetened tea instead.~Bi-weekly shipments of unsweetened beverages of participant's choice to replace usual consumption of NNS containing beverages.~Automated text messages will also be sent to mothers once per week with reminders that they should avoid NNS
Study NCT06548828 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Intervention
Description: Counsel about best practices for home safety and babyproofing.~Provide a detailed booklet to take home, which will provide information about home safety and baby proofing.~Educate about common causes of accidental infant and young child injuries or death.~Automated text messages will also be sent to mothers once per week with reminders about home safety, infant safety, and baby proofing.
Study NCT05571046 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucocorticoids
Description: Intramuscular injection of single dose of 1 ml betamethasone, Paracetamol (500 mg, 2 times a day)
Study NCT05571046 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intramuscular injection of %0.9 isotonic sodium chloride, Paracetamol (500 mg, 2 times a day)
Study NCT05066009 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NextSense EEG-enabled earbuds
Description: Each NextSense EEGBud device comes with a universal-fit and/or custom-fit earmold with biometric sensors to detect the EEG, motion (via tri-axial accelerometers), and heart rate. A unique custom mold is created employing a 3D printer to capture the geometry of a patients' ear and external auditory canal with a ring laser scanner to an accuracy of within 0.1 mm. This design process allows for a custom fit, and therefore both comfort and complete, consistent contact with the inner surface of the ear canal, providing high quality signal capture of brain activity, and head and eye movements. In addition to the custom fit earmold, universal fit earmolds are available as well. The universal fit earmolds were designed also to allow for comfort and consistent contact with the inner surface of the ear canal to provide high quality signal capture of brain activity, and head and eye movements.
Study NCT05066009 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ellcie Healthy eyeglasses
Description: Ellcie Healthy glasses frames are embedded with multi-modal sensors for measuring eye movements, head movement, and ECG.
Study NCT05066009 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Drug Holiday
Description: Participants will not take their prescribed wakefulness promoting medication(s) for one day to complete the study assessments. Medications typically used to promote wakefulness include amphetamine salts (Adderall), armodafinil (Nuvigil), clarithromycin (Biaxin), flumazenil, methylphenidate (Ritalin), and modafinil (Provigil).
Study NCT05737134 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MA_PESAN MOBILE APPLICATION
Description: The intervention group was given a mobile application consisting of video, and educational material that information was provided regarding the prevention of child sexual abuse.
Study NCT05452096 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education program and ergonomic schedulling
Description: The duration: six months. The explicit choice for a multimodal intervention to be tested as a whole is in line with the assertion of other experts that workplace interventions using a single approach will not be effective.~Multimodal intervention~1. Implementing healthy scheduling. This will imply fast forward-rotating shift schedules, being adapted to chronotype, allowing for adequate resting times between shifts and series of shifts, allowing for napping at work, in particular during the first two days of an early shift.~2. Education program for drivers: psychoeducation on the sleep-wake cycle chronotypes, based on the cognitive-behavioral treatment of insomnia (CBT-i), information on the impact of light on wakefulness and sleep, information on napping and creating awareness on daytime sleepiness, tools for stress reduction, physical exercise, information on healthy eating in the context of shiftwork The education program will consist of a one-day, 8-hour session.
Study NCT05087160 — intervention group
Intervention type: OTHER
Intervention: mitigation measures against COVID 19
Description: no intervention
Study NCT06196983 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhythmic aerobic exercises
Description: The experimental group's pattern of functional movements includes both right and left foot movements. To improve muscle strength and the capacity to maintain balance, exercises including running in place, side steps, walking while eating, and turning in place can also be used. The rhythmic aerobic group linked their motions to the rhythmic auditory stimuli in order to perform in a rhythmic manner.
Study NCT06196983 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group, strength and balance exercises
Description: The control group engaged in strength and balance exercises where they stood with weight on one leg and raised the other leg to the side or back. In a tandem stance, place your foot heel directly in front of your toe. Get out of a chair, then take a seat without using your hands.
Study NCT05431101 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Carpal Tunnel Release
Description: Transection of flexor retinaculum for patients who have carpal tunnel syndrome
Study NCT06181201 — intervention group
Intervention type: PROCEDURE
Intervention: Stool collection
Description: Stool collection is done with the Coll-off device (Zymo research, reference R1101-2-5) provided to the patient before and after the induction treatment and after the reference chemo-radiotherapy treatment (Cap50, Capecitabine). Collection must be carried out by the patient at home (collection using the Coll-off device and then transfer to a coproculture jar provided). The fresh sample is then picked up the same day by an approved transporter mandated by the promoter and will be stored at -20°C until the start of the analyses